Human gene therapy - JoVE Visualize

Showing results (571-580 of 4,123) with videos related to

Pageof 413

Sort By:

Human Gene Therapy|May 20, 1996

Systemic and portal vein delivery of human kallikrein gene reduces blood pressure in hypertensive ratsJ Chao, L Jin, L M Chen, et al.

Human Gene Therapy|May 20, 1996

Hepatic expression of the catalytic subunit of the apolipoprotein B mRNA editing enzyme (apobec-1) ameliorates hypercholesterolemia in LDL receptor-deficient rabbitsK F Kozarsky, D K Bonen, F Giannoni, et al.

Human Gene Therapy|November 5, 2016

miR-22 Inhibits CD34+ Cell Expansion Through Decreasing β-Catenin in OsteoblastsYuxia Yang, Yanju Zhang, Zhenchuan Miao, et al.

Human Gene Therapy|August 21, 2004

Chimeric RNA/ethylene-bridged nucleic acids promote dystrophin expression in myocytes of duchenne muscular dystrophy by inducing skipping of the nonsense mutation-encoding exonAgus Surono, Tran Van Khanh, Yasuhiro Takeshima, et al.

Human Gene Therapy|September 9, 2004

Functional characterization of a recombinant adeno-associated virus 5-pseudotyped cystic fibrosis transmembrane conductance regulator vectorJeffrey Sirninger, Christian Muller, Sofia Braag, et al.

Human Gene Therapy|September 9, 2004

A synthetic Rev-independent bovine immunodeficiency virus-based packaging constructRene P Molina, Hongqing Q Ye, James Brady, et al.

Human Gene Therapy|September 9, 2004

Trans-splicing adeno-associated viral vector-mediated gene therapy is limited by the accumulation of spliced mRNA but not by dual vector coinfection efficiencyZhuping Xu, Yongping Yue, Yi Lai, et al.

Human Gene Therapy|August 21, 2004

Lentivirus-mediated expression of mutant MGMTP140K protects human CD34+ cells against the combined toxicity of O6-benzylguanine and 1,3-bis(2-chloroethyl)-nitrosourea or temozolomideDhanalakshmi Chinnasamy, Leslie J Fairbairn, James Neuenfeldt, et al.

Human Gene Therapy|August 21, 2004

Therapeutic levels of factor IX expression using a muscle-specific promoter and adeno-associated virus serotype 1 vectorYi-Lin Liu, Federico Mingozzi, Sol M Rodriguéz-Colôn, et al.

Human Gene Therapy|June 24, 2004

Feline immunodeficiency virus vectors for efficient transduction of primary human synoviocytes: application to an original model of rheumatoid arthritisYea-Lih Lin, Danièle Noël, Clément Mettling, et al.

Pageof 413

Showing results (571-580 of 4,123) with videos related to

Sort By:

Pageof 413

Human Gene Therapy|May 20, 1996

Systemic and portal vein delivery of human kallikrein gene reduces blood pressure in hypertensive ratsJ Chao, L Jin, L M Chen, et al.

Human Gene Therapy|May 20, 1996

Hepatic expression of the catalytic subunit of the apolipoprotein B mRNA editing enzyme (apobec-1) ameliorates hypercholesterolemia in LDL receptor-deficient rabbitsK F Kozarsky, D K Bonen, F Giannoni, et al.

Human Gene Therapy|November 5, 2016

miR-22 Inhibits CD34+ Cell Expansion Through Decreasing β-Catenin in OsteoblastsYuxia Yang, Yanju Zhang, Zhenchuan Miao, et al.

Human Gene Therapy|August 21, 2004

Chimeric RNA/ethylene-bridged nucleic acids promote dystrophin expression in myocytes of duchenne muscular dystrophy by inducing skipping of the nonsense mutation-encoding exonAgus Surono, Tran Van Khanh, Yasuhiro Takeshima, et al.

Human Gene Therapy|September 9, 2004

Functional characterization of a recombinant adeno-associated virus 5-pseudotyped cystic fibrosis transmembrane conductance regulator vectorJeffrey Sirninger, Christian Muller, Sofia Braag, et al.

Human Gene Therapy|September 9, 2004

A synthetic Rev-independent bovine immunodeficiency virus-based packaging constructRene P Molina, Hongqing Q Ye, James Brady, et al.

Human Gene Therapy|September 9, 2004

Trans-splicing adeno-associated viral vector-mediated gene therapy is limited by the accumulation of spliced mRNA but not by dual vector coinfection efficiencyZhuping Xu, Yongping Yue, Yi Lai, et al.

Human Gene Therapy|August 21, 2004

Lentivirus-mediated expression of mutant MGMTP140K protects human CD34+ cells against the combined toxicity of O6-benzylguanine and 1,3-bis(2-chloroethyl)-nitrosourea or temozolomideDhanalakshmi Chinnasamy, Leslie J Fairbairn, James Neuenfeldt, et al.

Human Gene Therapy|August 21, 2004

Therapeutic levels of factor IX expression using a muscle-specific promoter and adeno-associated virus serotype 1 vectorYi-Lin Liu, Federico Mingozzi, Sol M Rodriguéz-Colôn, et al.

Human Gene Therapy|June 24, 2004

Feline immunodeficiency virus vectors for efficient transduction of primary human synoviocytes: application to an original model of rheumatoid arthritisYea-Lih Lin, Danièle Noël, Clément Mettling, et al.

Pageof 413